United Kingdom Surgical Glue Market

Market Snapshot

• UK Surgical Glue Market Size (2025): USD 66.45 Million
• Projected UK Surgical Glue Market Size (2035): USD 208.2 Million
• UK Surgical Glue Market Compound Annual Growth Rate (CAGR): 12.1%
• Market Base Year: 2025
• Historical Period: 2021–2024
• Forecast Period: 2026–2035

 

 

According to Decision Advisors, the United Kingdom Surgical Glue Market Size is expected to grow from USD 66.45 Million in 2025 to USD 208.2 Million by 2035, at a CAGR of 12.1% during the forecast period 2025-2035. The UK Surgical Glue Market is projected to grow significantly over the next decade. The market driven is by rising surgical procedures, technological advancements, and increasing preference for minimally invasive wound closure solutions.

 

Market Overview/Introduction

The United Kingdom Surgical Glue Market is defined as the specialized sector for biocompatible adhesives used to seal wounds and control bleeding as alternatives to traditional sutures. Growth is primarily boosted by an approximately 102% surge in cosmetic procedures and the rapid adoption of minimally invasive and robotic surgeries, which require precise, liquid-tight sealing. On the regulatory side, the UK government is carefully managing the shift from European CE labels to its own UKCA safety system. In the business world, things are moving just as fast. Local leaders like Advanced Medical Solutions are growing their footprint by snapping up specialist companies like Peters Surgical, while global giants like Ethicon and B. Braun are rolling out next-generation patches that can stop heavy bleeding almost instantly. Looking ahead, the real excitement is in smart adhesives. We are moving toward glues that don't just hold you together but actually use built-in sensors to monitor your healing in real-time, along with specialized formulas designed to stick perfectly to tricky, wet surfaces like the heart or lungs.

 

• To make sure surgeons don’t run out of the latest tools during this transition, they’ve extended the deadlines until 2028 or 2030, giving manufacturers plenty of breathing room.

 

Notable Insights: -

1. By type, the cyanoacrylate-based adhesives segment dominated the market in 2025, accounting for approximately 45% of market share, and is projected to grow at a substantial CAGR during the forecast period.
2. By end user, the hospitals segment dominated the market in 2025, accounting for approximately 65% of market share, and is projected to grow at a substantial CAGR during the forecast period.
3. The compound annual growth rate of the UK Surgical Glue Market is 12.1%.
4. The market is likely to achieve a valuation of USD 208.2 Million by 2035.

 

What is the role of technology in grooming the market?

Technological advancements are significantly shaping the UK surgical glue market through the development of bio-compatible and biodegradable adhesives. Innovations such as antimicrobial surgical glues and advanced fibrin sealants are enhancing patient safety and reducing post-surgical complications. New formulations provide stronger adhesion, faster curing time, and improved flexibility, making them suitable for complex surgical procedures. Integration with robotic-assisted surgeries and laparoscopic techniques is further expanding their application scope. These innovations have contributed to reducing surgical closure time by up to 30% and improving healing efficiency.

 

Market Drivers

The growth of the UK surgical glue market is really being fuelled by two things, more surgeries happening overall and a major shift toward keyhole or minimally invasive techniques. As our population ages and more people deal with long-term health issues like heart disease or arthritis, the demand for these procedures is only going up. At the same time, doctors are reaching for surgical glues more often because they’re simply faster to use than traditional stitches, they lower the risk of infection, and they leave much neater scars. With the government continuing to invest in healthcare and medical tech constantly evolving, the market for these adhesives is seeing some serious momentum.

 

Study on the Supply, Demand, Distribution, and Market Environment of the UK Surgical Glue Market

The UK surgical glue market operates within a well-structured healthcare ecosystem supported by public and private stakeholders. On the supply side, the market includes medical device manufacturers, biotechnology firms, and distributors supplying advanced adhesive products. Demand is driven by hospitals, ambulatory surgical centers, and specialty clinics performing a high volume of surgeries. Efficient distribution channels and procurement systems within the NHS ensure product accessibility. The market environment is favorable due to high healthcare expenditure and rapid adoption of innovative surgical solutions. However, strict regulatory requirements and product approval processes may pose challenges for new entrants.

 

Price Analysis and Consumer Behaviour Analysis

Pricing of surgical glue products varies depending on type and application:

• Cyanoacrylate adhesives: USD 20 – USD 80 per unit.
• Fibrin sealants: USD 150 – USD 500 per procedure.
• Collagen-based adhesives: USD 100 – USD 400 per unit

From a consumer behavior perspective, purchasing decisions are primarily influenced by clinical effectiveness, safety, and ease of use. Surgeons prefer products that provide strong adhesion and reduce complications. Cost plays a secondary role, particularly in publicly funded healthcare settings where reimbursement policies support advanced treatments.

 

Market Segmentation

The UK Surgical Glue Market share is classified into product type, application, and end user.

• The cyanoacrylate-based adhesives segment dominated the market in 2025, accounting for approximately 45% of market share, and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the UK surgical glue market is divided into cyanoacrylate-based adhesives, fibrin sealants, collagen-based adhesives, and synthetic polymer adhesives. Among these, the cyanoacrylate-based adhesives segment dominated the market in 2025, accounting for approximately 45% of market share, and is projected to grow at a substantial CAGR during the forecast period. Cyanoacrylate adhesives dominate due to their rapid polymerization, strong bonding strength, and ease of application, making them highly effective for wound closure in both emergency and surgical settings. However, fibrin sealants are gaining traction due to their biological compatibility, hemostatic properties, and increasing use in complex internal surgeries, particularly in cardiovascular and soft tissue procedures.

 

• The general surgery segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the UK surgical glue market is divided into cardiovascular surgery, general surgery, orthopedic surgery, cosmetic & plastic surgery, and others. Among these, the general surgery segment accounted for the largest share in 2025 and is anticipated to grow at a significant CAGR during the forecast period. Surgical glues are widely used in general surgical procedures for wound closure, sealing tissues, and reducing operation time. The increasing volume of surgeries and the growing preference for minimally invasive techniques are significantly driving this segment. Additionally, the cosmetic & plastic surgery segment is expanding due to rising demand for improved aesthetic outcomes with minimal scarring and faster healing.

 

• The hospitals segment dominated the market in 2025, accounting for approximately 65% of market share, and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the UK surgical glue market is divided into hospitals, specialty clinics, and ambulatory surgical centers. Among these, the hospitals segment dominated the market in 2025, accounting for approximately 65% of market share, and is projected to grow at a substantial CAGR during the forecast period. Hospitals dominate due to the presence of advanced surgical infrastructure, availability of skilled professionals, and high patient inflow requiring surgical interventions. A large proportion of complex procedures utilizing surgical adhesives are performed in hospital settings, reinforcing their leading position. Specialty clinics and ambulatory surgical centers are gradually expanding due to the increasing shift toward outpatient and minimally invasive procedures, but they continue to hold a smaller share compared to hospitals.

 

Recent Development

• In May 2025, Grena Ltd. announced the expansion and promotion of its advanced surgical adhesive NE'X GLUE across the UK market. The product is designed to enhance surgical safety and efficiency by providing strong tissue adhesion and improved healing outcomes. The launch highlights the growing shift toward next-generation surgical glues that support faster recovery and reduce complications in surgical procedures.

 

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the UK surgical glue market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Key Companies in the UK Surgical Glue Market

• Johnson & Johnson
• Baxter International Inc.
• B. Braun Melsungen AG
• Medtronic plc
• CryoLife Inc

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the United Kingdom, regional, and country levels from 2020 to 2035. Decision Advisors has segmented the UK surgical glue market based on the below-mentioned segments

 

UK Surgical Glue Market, By Product Type

• Cyanoacrylate-based Adhesives
• Fibrin Sealants
• Collagen-based Adhesives
• Synthetic Polymer Adhesives

 

UK Surgical Glue Market, By Application

• Cardiovascular Surgery
• General Surgery
• Orthopedic Surgery
• Cosmetic & Plastic Surgery
• Others

 

UK Surgical Glue Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

 

Frequently Asked Questions (FAQ)

Q. How do storage conditions affect the performance of surgical glue products?

A. Surgical glues, especially fibrin-based and biologic adhesives, require controlled storage conditions such as refrigeration to maintain their efficacy. Improper storage can reduce bonding strength and shelf life, impacting clinical performance.

 

Q. What training is required for surgeons to effectively use surgical glues?

A. While surgical glues are relatively easy to use, proper training is essential to ensure correct application techniques, dosage control, and optimal bonding outcomes, particularly in complex or internal procedures.

 

Q. How do surgical glues perform in high-moisture or bleeding environments?

A. Advanced formulations such as fibrin sealants and synthetic polymer adhesives are specifically designed to perform well in moist or bleeding conditions, providing effective sealing and hemostasis during surgeries.

 

Q. What environmental or sustainability concerns are associated with surgical glue products?

A. Some synthetic adhesives may raise concerns regarding biodegradability and medical waste. However, newer biodegradable and bio-based glues are being developed to address environmental sustainability issues.

 

Q. How does product shelf-life influence purchasing decisions in healthcare facilities?

A. Shelf life plays a crucial role, especially in hospitals and outpatient centers. Products with longer shelf life reduce wastage, improve inventory management, and are preferred in facilities with variable surgical volumes.